alzheimer 's disease is being redefined for the first time in 27 years , with new medical guidelines reflecting the fact that the disease is a " continuum . " growing evidence shows that alzheimer 's starts affecting the brain years before dementia symptoms present themselves , and the new guidelines reflect that by dividing the disease into three stages : end-stage dementia , a middle phase involving mild problems , and a symptomless beginning stage where the brain has already begun to change . " i think we â€™ re going to start to identify it earlier and earlier , " says one expert . the new guidelines are concerned with measuring biomarkers , or indicators that a person will likely develop dementia , in clinical trial patients , the new york times reports . the wall street journal notes that earlier diagnosis of the disease will also allow earlier intervention , and could someday allow patients to take alzheimer's-slowing drugs earlier .
